Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Synthesis and biological evaluation of N-alkyl naphthoimidazoles derived from ß-lapachone against Trypanosoma cruzi bloodstream trypomastigotes.

da Silva, Ari Miranda; Araújo-Silva, Leonardo; Bombaça, Ana Cristina S; Menna-Barreto, Rubem F S; Rodrigues-Santos, Claudio Eduardo; Buarque Ferreira, Aurélio B; de Castro, Solange L.
Medchemcomm; 8(5): 952-959, 2017 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-30108809
The QSAR study of 34 2-aryl-naphthoimidazoles screened so far revealed that σi is the most important factor for their lytic activity on the bloodstream trypomastigote forms of T. cruzi, the etiologic agent of Chagas disease. Based on this result, 16 new N-alkyl-naphthoimidazoles derived from 6,6-dimethyl-3,4,5,6-tetrahydrobenzo[7,8]chromene[5,6-d]imidazole (the product of the reaction of ß-lapachone with paraformaldehyde) by its reaction with halo-alkanes were prepared and evaluated against the parasite and peritoneal macrophages. The N1-n-hexyl and N3-n-hexyl naphthoimidazoles were 2.2 and 3.2 times more active than the standard drug benznidazole with selectivity indices of 2.7 and 13.4, respectively.
Selo DaSilva